difference between retatrutide and tirzepatide How Is Compared to Tirzepatide? Full Comparison what is the max dose

Side effect tolerability varies enormously between individuals

This initial consultation typically involves a thorough review of your medical history, including any pre-existing conditions like diabetes, heart disease, or thyroid issues

If youre eating fewer calories but those calories come primarily from processed foods, refined sugars, or alcohol, your results will likely stall

Standard FDA-approved dosing escalation The FDA-approved tirzepatide dosing schedule, used in the SURMOUNT and SURPASS clinical trials, follows this pattern: Weeks 1 to 4: 2.5 mg once weekly (starting dose) Weeks 5 to 8: 5 mg once weekly Weeks 9 to 12: 7.5 mg once weekly (optional increase) Weeks 13 to 16: 10 mg once weekly (optional increase) Weeks 17 to 20: 12.5 mg once weekly (optional increase) Week 21 and beyond: 15 mg once weekly (maximum dose) Each dose increase happens after a minimum of four weeks at the current dose

Boxed Warning for Thyroid C-Cell Tumors : The medication comes with a boxed warning regarding the potential risk of thyroid C-cell tumors, emphasizing the need for careful consideration and consultation with healthcare professionals